AZ’s Tagrisso gets full US approval in lung cancer
Phase 3 data confirmed its efficacy in patients with a certain mutation.
X
AZ’s Tagrisso gets full US approval in lung cancer
https://pharmaphorum.com/news/azs-tagrisso-gets-full-us-approval-lung-cancer/